PDX INSIGHTS
PIONEERING CANCER RESEARCH
Home
Collections
Bladder
Breast
Leukemia
Liver
Pancreas
Sarcoma
Omics Tools
Management
Data Management
File Management
Publications
Contact Us
Log In
You need to enable JavaScript to run this app page.
Pancreas Collection
Filter Data:
Institution:
BCM
BCM
Privacy:
Public and Private
Public Only
Private Only
Patient/PDX:
Patients (25)
PDX (25)
Submit
Collection Summaries:
Collection Details:
Search All Columns:
Total models showing: 25
F
P
1
2
N
E
Rows Per Page
10
15
25
50
Download
Model ID
Filter by Model ID
Patient ID
Filter by Patient ID
Pathology Diagnosis
Select
Adenocarcinoma (pancreatobiliary)
High grade Adenocarcinoma
Pancreatic ductal adenocarcinoma
Patient Biomarkers
NCCN Stage
Select
Resectable
Borderline
Metastatic
BMI
Select
<20
20-25
25-30
30-35
>35
Survival in Months
Filter by Survival in Months
Age at Diagnosis
Select
41-50
51-60
61-70
>70
Race
Select
Asian
Black or African American
Hispanic or Latino
White
White,Hispanic or Latino
Gender
Select
Female
Male
Grade
Select
G2
G2.5
G3
G4
Not Reported
Path Stage
Select
IB
IIA
IIB
III
IV
Not Reported
Patient Treatment
Filter by Patient Treatment
CA 19-9
Filter by CA 19-9
Bilirubin
Filter by Bilirubin
Risk Factor
Filter by Risk Factor
BCM-PAN-11
3429743
Pancreatic ductal adenocarcinoma
23.5
0.6
24.0
12
40.89
White
Male
G2
IIB
Folfox,Gemcitabine
BCM-PAN-3
5126872
Pancreatic ductal adenocarcinoma
5
0.8
Pancreatitis
Resectable
26.6
25
55.19
Black or African American
Male
G3
IIA
BCM-PAN-5
3333427
Pancreatic ductal adenocarcinoma
25.8
8.6
Resectable
23.0
15
69.9
White,Hispanic or Latino
Female
G2
IIB
Fluorouracil,Gemcitabine
BCM-PDAC-1
4622397
Pancreatic ductal adenocarcinoma
79.2
3.5
Tobacco
Borderline
21.3
55
58.43
White
Male
G2
IIB
Abraxane,Capecitabine,Gemcitabine
BCM-PDAC-10
5695792
Pancreatic ductal adenocarcinoma
79
0.8
Tobacco, Pancreatitis
Resectable
21.0
27
58.14
White
Female
G2
IIB
Folfirinox
BCM-PDAC-11
6046120
High grade Adenocarcinoma
Tobacco, Pancreatitis
Resectable
23.75
23
59.9
White
Male
G3
IIB
Abraxane,Capecitabine,Folfirinox,Folfox,Gemcitabine
BCM-PDAC-13
6125394
Pancreatic ductal adenocarcinoma
106
0.2
Diabetes, Tobacco, Pancreatitis
Resectable
22.5
14
64.75
Hispanic or Latino
Male
G3
IIB
Abraxane,Gemcitabine
BCM-PDAC-14
6142831
Pancreatic ductal adenocarcinoma
401.2
0.5
Diabetes
Resectable
40.05
12
64.32
White
Female
G2
IIB
Gemcitabine
BCM-PDAC-18
6652135
Pancreatic ductal adenocarcinoma
Diabetes
Resectable
30.75
42
65.02
White
Male
G2
IIB
Abraxane,Capecitabine,Gemcitabine
BCM-PDAC-19
6714659
Pancreatic ductal adenocarcinoma
2600
2.4
Tobacco, Diabetes
Resectable
29.3
17
71.97
White
Female
G2
IIB
Gemcitabine
BCM-PDAC-2
4639492
Pancreatic ductal adenocarcinoma
192.2
0.6
Tobacco
Resectable
22.24
15
88.58
White
Male
G2
IIB
BCM-PDAC-25
8471998
Pancreatic ductal adenocarcinoma
988
16.5
Resectable
39.0
6
66.13
White
Male
G3
IIB
folfirinox
BCM-PDAC-26
8635396
Pancreatic ductal adenocarcinoma
186
0.6
Resectable
22.06
15
46.68
Black or African American
Female
G2
IIB
Gemcitabine,capecitabine
BCM-PDAC-28
8944795
Adenocarcinoma (pancreatobiliary)
Tobacco
Resectable
28.11
21
59.08
White
Male
G2.5
IV
Abraxane with investigational agent (HALO 301),Gemcitabine
BCM-PDAC-29
8988670
Pancreatic ductal adenocarcinoma
534
0.3
Diabetes, Tobacco, Pancreatitis
Resectable
47.01
28
65.43
Black or African American
Female
G2
IIA
Abraxane,Capecitabine,Gemcitabine,capecitabine
Total models showing: 25
F
P
1
2
N
E
Rows Per Page
10
15
25
50
Download
* indicates the model is private.
+ indicates the patient has multiple models.
Site Filter Error
At least one site must be selected to show collection data.
OK
Please wait...
